Hasil Pencarian
	Ditemukan 946 dokumen dengan kata kunci 9084 Simpan CSV  Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.9, 1 May, 2013: p.595-605 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p54-59 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck† No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p. 761-769 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.145-152 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC) No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1615-1622 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.4, 20 February, 2013: p.266-273 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer No. Panggil: Annals of Oncology; Volume 24: No.1 Januari 2013, p.145-152 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.59-66 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1630-1639 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.67-74 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next